Literature DB >> 10436342

Neurons and their dendrites in frontotemporal dementia.

I Ferrer1.   

Abstract

Regional and areal patterns of cell vulnerability (manifested as cell death and neuron loss) and cell sensitivity (as revealed by the presence of intracytoplasmic inclusions) are described in patients with frontotemporal dementia (FTD) and FTD+ motor neuron disease (MND). This is followed by studies geared to learning about possible mechanisms involved in selective neuron loss and studies focused on recognizing the identity of vulnerable populations of local-circuit neurons and the impact of FTD on individual cells as well as on postsynaptic and presynaptic terminals in the frontal cortex. Neuron loss is not associated with increased vulnerability to nuclear DNA fragmentation, and nor is it accompanied by modifications in the expression of the proteins Bcl-2 and Bax, and transcription factors c-Fos and c-Jun, thus suggesting that these proteins are probably not involved in cell death in these disorders. In the frontal and temporal cortices, glutamatergic pyramidal cells and calbindin-D28k-immunoreactive GABAergic local-circuit neurons are lost in the upper cortical layers. Parvalbumin-immunoreactive cells are preserved. In addition, reduction of putative postsynaptic sites (as inferred from the decreased numbers of dendritic branches in both pyramidal and nonpyramidal neurons, and of dendritic spines in pyramidal cells) in remaining neurons of the upper layers, as well as reduction of presynaptic terminals (as suggested by the decreased expression of synaptic vesicle-associated proteins, synaptophysin, synaptotagmin, rab 3a and synapsin 1, and presynaptic plasma membrane proteins SNAP-25 and syntaxin 1) in the upper layers of the frontal cortex, but not of the posterior parietal cortex, demonstrate the combined devastating effects of FTD on cortico-cortical connections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10436342     DOI: 10.1159/000051214

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  40 in total

Review 1.  Synapse loss in dementias.

Authors:  Ryan Clare; Victoria G King; Martin Wirenfeldt; Harry V Vinters
Journal:  J Neurosci Res       Date:  2010-08-01       Impact factor: 4.164

2.  Morphological Bases of Neuronal Hyperexcitability in Neurodegeneration.

Authors:  Ti-Fei Yuan; Bo Peng; Sergio Machado; Oscar Arias-Carrion
Journal:  CNS Neurosci Ther       Date:  2015-11       Impact factor: 5.243

3.  Activity-Dependent Reconnection of Adult-Born Dentate Granule Cells in a Mouse Model of Frontotemporal Dementia.

Authors:  Julia Terreros-Roncal; Miguel Flor-García; Elena P Moreno-Jiménez; Noemí Pallas-Bazarra; Alberto Rábano; Nirnath Sah; Henriette van Praag; Damiana Giacomini; Alejandro F Schinder; Jesús Ávila; Maria Llorens-Martín
Journal:  J Neurosci       Date:  2019-05-27       Impact factor: 6.167

Review 4.  Medical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategies.

Authors:  Gregory A Jicha
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

5.  Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.

Authors:  Gregory A Jicha; Peter T Nelson
Journal:  Neurodegener Dis Manag       Date:  2011-04

Review 6.  A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia.

Authors:  Edward D Huey; Karen T Putnam; Jordan Grafman
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

7.  CHMP2B mutants linked to frontotemporal dementia impair maturation of dendritic spines.

Authors:  Agnès Belly; Gilles Bodon; Béatrice Blot; Alexandre Bouron; Rémy Sadoul; Yves Goldberg
Journal:  J Cell Sci       Date:  2010-08-10       Impact factor: 5.285

8.  Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy.

Authors:  D M Bowen; A W Procter; D M A Mann; J S Snowden; M M Esiri; D Neary; P T Francis
Journal:  Psychopharmacology (Berl)       Date:  2007-11-18       Impact factor: 4.530

9.  Transferrin-receptor-mediated iron accumulation controls proliferation and glutamate release in glioma cells.

Authors:  S R Chirasani; D S Markovic; M Synowitz; S A Eichler; P Wisniewski; B Kaminska; A Otto; E Wanker; M Schäfer; P Chiarugi; J C Meier; H Kettenmann; R Glass
Journal:  J Mol Med (Berl)       Date:  2008-12-09       Impact factor: 4.599

10.  GABA-ergic Dynamics in Human Frontotemporal Networks Confirmed by Pharmaco-Magnetoencephalography.

Authors:  Natalie E Adams; Laura E Hughes; Holly N Phillips; Alexander D Shaw; Alexander G Murley; David Nesbitt; Thomas E Cope; W Richard Bevan-Jones; Luca Passamonti; James B Rowe
Journal:  J Neurosci       Date:  2020-01-08       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.